Skip to content

Saliva metabolome study in human

Saliva metabolome study in human: an observational study - Saliva metabolome study in human

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000048790
Enrollment
22
Registered
2022-08-30
Start date
2022-08-30
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Japanese subjects

Interventions

None listed

Sponsors

ORTHOMEDICO Inc.
Lead Sponsor
Medical Corporation Seishinkai, Takara Clinic Nerima Medical Association, Minami-machi Clinic
Collaborator

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. Japanese 2. Men 3. Subjects aged 45 or more and less than 60 4. Healthy subjects 5. Subjects who work a five-day week 6. Subjects who meet the above inclusion criteria (1. to 5.) and meet the below criteria (a. or b.) (*A total of 160 subjects {80 subjects in each criterion (a. or b.)} will be selected) a. Subjects who are concerned about their sleep quality b. Subjects who are not concerned about their sleep quality 7. Subjects who meet the above inclusion criteria (1. to 6.) and meet the below criteria (c. or d.) based on the results of PSQI in the screening observation period (*A total of 22 subjects {11 subjects in each criterion (c. or d.)} will be selected) c. Subjects whose score of PSQI is two or less d. Subjects whose score of PSQI is six or more

Exclusion criteria

Exclusion criteria: 1. Subjects who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, and myocardial infarction 2. Subjects who have a pacemaker or an implantable cardioverter defibrillator (ICD) 3. Subjects currently undergoing treatment for any of the following chronic diseases: cardiac arrhythmia, liver disorder, kidney disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases 4. Subjects who use or take "Foods for Specified Health Uses," or "Foods with Functional Claims" in daily 5. Subjects who are currently taking medications (including herbal medicines) and supplements 6. Subjects who are allergic to medications 7. Subjects who are pregnant, lactating, or planning to become pregnant during this trial 8. Subjects who suffer from COVID-19 9. Subjects who have been enrolled in other clinical trials within the last 28 days before the agreement to participate in this trial or plan to participate another trial during this trial 10. Subjects who are judged as ineligible to participate in this study by the physician

Design outcomes

Primary

MeasureTime frame
Metabolome analysis and multiple testing corrections (q-value)

Secondary

MeasureTime frame
The Pittsburgh Sleep Quality Index (PSQI) Japanese version and the St. Mary's Hospital sleep questionnaire (SMH)

Countries

Japan

Contacts

Public ContactNaoko Suzuki

ORTHOMEDICO Inc. R&D Department

nao@orthomedico.jp03-3818-0610

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026